БЛОГ

Archive for the ‘health’ category: Page 207

Mar 27, 2020

The Prince of England, next in line to the trone has coronavirus

Posted by in categories: biotech/medical, health

#JustSaying


The Prime Minister of England has coronavirus. The Health Minister of England has coronavirus.

Mar 27, 2020

Is big tech good for your health? | The Economist

Posted by in categories: biotech/medical, health

Tech giants including Google and Microsoft want to work with hospitals and health-care systems to improve lives. But should people trust them with their medical data?

For more from Economist Films visit: http://films.economist.com/

Mar 26, 2020

Clinical trials may begin next week in New York for coronavirus treatments: Health official

Posted by in categories: biotech/medical, health

Officials are working out final details in plans to begin clinical trials next week for a malaria drug combination that appears to hold some promise for confronting the coronavirus pandemic.

New York state Health Department officials are making arrangements to determine what patients at which hospitals will be allowed to participate in trials with hydroxychloroquine, Zithromax and chloroquine, a senior official at the department with knowledge of the plan told ABC News. The bulk of the patients are expected to be in the New York City metro area because the region has the biggest cluster of cases.


New York Gov. Andrew Cuomo announced earlier this week that he was eager to get the trials started. By Tuesday, the drugs were in New York and officials were working to identify who could participate.

Continue reading “Clinical trials may begin next week in New York for coronavirus treatments: Health official” »

Mar 26, 2020

Former Taiwan Premier Offers Lessons on How the U.S. Should Deal With COVID-19

Posted by in categories: biotech/medical, health

The last point is that Taiwan has a very good healthcare system, especially compared with the U.S. Taiwan’s health insurance system is affordable for the general public, which means everyone can get a medical examination or hospital treatment when necessary. It is also a scientific one: The health insurance system collects personal data and medical records, so hospitals and doctors can make good judgments about every patient’s condition. The quality of the national health system is quite important in the healing of patients and the containment of coronavirus.


Taiwan’s coronavirus response so far has been exemplary. Other nations, especially the U.S., should take note, says former Taiwan Premier Jiang Yi-huah.

Mar 26, 2020

UK Plans to Roll Out 15-Minute Home Coronavirus Test Kits This Week

Posted by in categories: biotech/medical, government, health

Healthcare professionals and infectious disease experts around the world agree that extensive testing is the best way to combat coronavirus. However, the extreme shortage of COVID-19 testing kits has made that impossible. The Public Health England (PHE) just announced it was planning to begin rolling out at-home COVID-19 testing kits in the coming days. These tests could tell people if they’ve been infected with COVID-19 in as little as 15 minutes.

Current coronavirus testing is time-consuming and expensive because it requires healthcare practitioners to collect samples from the patient and have them processed in a laboratory. The test promised by the UK government would look like a pregnancy test and needs just a drop of blood to diagnose the individual.

Several companies are working on at-home COVID-19 tests, but PHE didn’t say which test it planned to deploy. According to PHE, the unnamed test takes 15 minutes to work, and it will be available at pharmacies and online via retailers like Amazon. The test will detect antibodies in the user’s blood that indicate they have been exposed to the SARS-CoV-2 virus. It works with both Immunoglobulin M and Immunoglobulin G (IgM and IGG) type antibodies. IgM peaks early in an infection and IgG remains even after the infection has subsided.

Mar 25, 2020

Mapping the cannabis genome to improve crops and health

Posted by in categories: biotech/medical, food, genetics, health

:ooooo.


Unlocking the full potential of cannabis for agriculture and human health will require a co-ordinated scientific effort to assemble and map the cannabis genome, says a just-published international study led by University of Saskatchewan researchers.

In a major statistical analysis of existing data and studies published in the Annual Review of Plant Biology, the authors conclude there are large gaps in the scientific knowledge of this high-demand, multi-purpose crop.

Continue reading “Mapping the cannabis genome to improve crops and health” »

Mar 25, 2020

Biowarfare Experts On Coronavirus (COVID19)

Posted by in categories: biotech/medical, health, media & arts, military

Excellent interview:


Dr. Gerald Parker Associate Dean for Global One Health at Texas A&M and Professor Andrew S Natsios Executive Professor at The Bush School and Director of the Scowcroft Institute of International Affairs have a sit down with Patrick Bet-David about the Coronavirus Pandemic. About our guests Dr. Gerald Parker https://bit.ly/2IZPRAl Professor Andrew S. Natsios https://bit.ly/2UkWBy6

Continue reading “Biowarfare Experts On Coronavirus (COVID19)” »

Mar 25, 2020

A nanoscale device to generate high-power terahertz waves

Posted by in categories: biotech/medical, health, nanotechnology, security, sustainability

Terahertz (THz) waves fall between microwave and infrared radiation in the electromagnetic spectrum, oscillating at frequencies of between 100 billion and 30 trillion cycles per second. These waves are prized for their distinctive properties: they can penetrate paper, clothing, wood and walls, as well as detect air pollution. THz sources could revolutionize security and medical imaging systems. What’s more, their ability to carry vast quantities of data could hold the key to faster wireless communications.

THz waves are a type of non-ionizing radiation, meaning they pose no risk to human health. The technology is already used in some airports to scan passengers and detect dangerous objects and substances.

Despite holding great promise, THz waves are not widely used because they are costly and cumbersome to generate. But new technology developed by researchers at EPFL could change all that. The team at the Power and Wide-band-gap Electronics Research Laboratory (POWERlab), led by Prof. Elison Matioli, built a nanodevice that can generate extremely high-power signals in just a few picoseconds, or one trillionth of a second, which produces high-power THz waves.

Mar 25, 2020

COVID19 Impact Part II – SpaceX , SLS and NASA

Posted by in categories: disruptive technology, health, space, space travel

By Bill D’Zio March 25, 2020

SpaceX Dragon
SpaceX Crew Dragon on approach Credit NASA

Part 2 of the Life in Space with COVID19 we will delve into Crew demo-2 where NASA and SpaceX are planning a launch within two months. There are a lot of pre-launch milestones and activities to cover to ensure a safe flight for the Astronauts. If anything goes wrong, there are lives at stake. Now NASA and SpaceX have to contend with another potential setback, COVID19 pandemic. (Click here for part I)

The SpaceX Crew Dragon spacecraft for Demo-2 arrived at the launch site on Feb. 13, 2020. Photo credit: SpaceX

In Part I of why COVID19 pandemic is bad timing for the Space industry, we covered that issues happen because the relationship between complexity, risk, schedule and cost for space missions was not balanced.

Continue reading “COVID19 Impact Part II – SpaceX , SLS and NASA” »

Mar 24, 2020

FDA Grants Experimental Coronavirus Drug Benefits For Rare Disease Treatments

Posted by in categories: biotech/medical, health

The agency’s decision would provide lucrative incentives to the drug’s maker, Gilead Sciences, and could keep lower-priced generic versions of the medicine off the market for several years if remdesivir is approved for use, public health advocates say.


Remdesivir Gets Rare Disease Perks From FDA : Shots — Health News Gilead Science’s remdesivir, an antiviral medicine being tested for treatment of COVID-19, would get a seven-year monopoly if approved by the Food and Drug Administration.